We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NU market cap is 879.81k. The company's latest EPS is CAD and P/E is N/A.
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 82k | 97k | 74k | 81k | 462k |
Operating Income | -1.97M | -1.14M | -935k | -1.08M | -191k |
Net Income | -2.38M | -1.61M | -1.95M | -1.57M | -771k |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 553k | 505k | 528k | 819k | 331k |
Total Liabilities | 278k | 661k | 618k | 867k | 948k |
Total Equity | 275k | -156k | -90k | -48k | -617k |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -2.05M | -1.24M | -1.52M | -1.04M | -165k |
Investing | -28k | N/A | -110k | -107k | -5k |
Financing | 1.99M | 966k | 1.64M | 1.17M | 315k |
Market Cap | 879.81k |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 175.96M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | 0.00% |
52 Week High | 0.01 |
52 Week Low | 0.005 |
Spread (Intraday) | 0.01 (50%) |
Company Name | NeutriSci International Inc |
Address |
2200 - 885 west georgia street vancouver, british columbia V6C 3E8 |
Website | https://www.neutrisci.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions